ARAV Company Profile and Key Details
Aravive, Inc.
ARAV Stock Price Chart
Stock Price Today
Aravive, Inc. (ARAV) stock declined over -13.39%, trading at $0.04 on NASDAQ, down from the previous close of $0.05. The stock opened at $0.04, fluctuating between $0.04 and $0.05 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a strategic collaboration agreement with WuXi Biologics (Hong Kong) Limited to develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain batiraxcept as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas.
Company Information
| Employees | 23 |
| Beta | 2.19 |
| Sales or Revenue | $9.14M |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Aravive, Inc. (NASDAQ: ARAV) stock price is $0.04 in the last trading session. During the trading session, ARAV stock reached the peak price of $0.05 while $0.04 was the lowest point it dropped to. The percentage change in ARAV stock occurred in the recent session was -13.39% while the dollar amount for the price change in ARAV stock was -$0.01.
The NASDAQ listed ARAV is part of Biotechnology industry that operates in the broader Healthcare sector. Aravive, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Fredric N. Eshelman Pharm.D.
Executive Chairman
Dr. Gail F. McIntyre CH (ASCP), DABT, Ph.D.
Pres, Chief Executive Officer & Director
Dr. Randy L. Anderson
Senior Vice President of Data Sciences
Dr. Robert B. Geller M.D.
Chief Medical Officer
Ms. Carolina Petrini
Chief Commercial Officer
Dr. Jeffrey L. Cleland Ph.D.
Co-Founder
Dr. Joshua Silverman Ph.D.
Co-Founder
Mr. Marek Ciszewski J.D.
Senior Vice President of Investor Relations
Mr. Rudy C. Howard B.A., CPA, CPA
Chief Financial Officer
Dr. Leonard Scott Dove Ph.D.
Chief Operating Officer
Kenneth L. Guernsey
Sec.
ARAV's closing price is 0.25% higher than its 52-week low of $0.04 where as its distance from 52-week high of $2.46 is -98.37%.
Number of ARAV employees currently stands at 23.
Official Website of ARAV is: https://aravive.com
ARAV could be contacted at phone 936 355 1910 and can also be accessed through its website. ARAV operates from River Oaks Tower, Houston, TX 77098, United States.
ARAV stock volume for the day was 4.04M shares. The average number of ARAV shares traded daily for last 3 months was 2.24M.
The market value of ARAV currently stands at $2.95M with its latest stock price at $0.04 and 73.56M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com